HomeCompareSMED vs EQR

SMED vs EQR: Dividend Comparison 2026

SMED yields 22.86% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SMED wins by $39.1K in total portfolio value
10 years
SMED
SMED
● Live price
22.86%
Share price
$8.75
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$86.9K
Annual income
$9,043.33
Full SMED calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — SMED vs EQR

📍 SMED pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSMEDEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SMED + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SMED pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SMED
Annual income on $10K today (after 15% tax)
$1,942.86/yr
After 10yr DRIP, annual income (after tax)
$7,686.83/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, SMED beats the other by $3,032.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SMED + EQR for your $10,000?

SMED: 50%EQR: 50%
100% EQR50/50100% SMED
Portfolio after 10yr
$67.3K
Annual income
$7,259.46/yr
Blended yield
10.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

SMED
No analyst data
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SMED buys
0
EQR buys
0
No recent congressional trades found for SMED or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSMEDEQR
Forward yield22.86%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$86.9K$47.8K
Annual income after 10y$9,043.33$5,475.61
Total dividends collected$52.8K$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: SMED vs EQR ($10,000, DRIP)

YearSMED PortfolioSMED Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$12,986$2,285.71$11,380$679.82+$1.6KSMED
2$16,669$2,773.98$13,014$837.25+$3.7KSMED
3$21,163$3,327.79$14,961$1,036.20+$6.2KSMED
4$26,593$3,948.70$17,297$1,289.22+$9.3KSMED
5$33,092$4,637.26$20,121$1,613.15+$13.0KSMED
6$40,802$5,392.98$23,561$2,030.84+$17.2KSMED
7$49,872$6,214.37$27,783$2,573.54+$22.1KSMED
8$60,462$7,098.94$33,013$3,284.39+$27.4KSMED
9$72,738$8,043.32$39,547$4,223.51+$33.2KSMED
10$86,873$9,043.33$47,791$5,475.61+$39.1KSMED

SMED vs EQR: Complete Analysis 2026

SMEDStock

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System to treat used needles, syringes, and other used healthcare products; Route-Based Pickup Service, a medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and disposal of unwanted and expired ultimate-user medications. The company also provides TakeAway Medication Recovery System that facilitates the proper disposal of unused medications; Black Pail Program for Rx, a solution with minimal segregation for the disposal of various pharmaceuticals; Inhaler Disposal to collect, transport, and destroy used pharmaceutical inhalers; Hazardous Drug Spill Control Kit for the cleanup of chemotherapy and other HD spills; TakeAway Recycle System for the collection and recycling of single-use medical devices from surgical centers and other healthcare facilities; ComplianceTRAC, a Web-based compliance and training program; and Universal Waste Shipback Systems to collect, transport, and recycle light bulbs, batteries, and other mercury containing devices. In addition, it offers other solutions, such as TakeAway Environmental Return System, SharpsTracer, Sharps Secure, Needle Disposal System, Complete Needle Collection and Disposal System, Pitch-It IV Poles, Asset Return System, and Spill Kit Recovery System, as well as Sharps MWMS, a medical waste management system. The company serves customers in home health care, retail clinics and immunizing pharmacies, pharmaceutical manufacturers, professional offices, assisted living and long-term care facilities, and government agencies, as well as distributors. Sharps Compliance Corp. was founded in 1992 and is headquartered in Houston, Texas.

Full SMED Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this SMED vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SMED vs SCHDSMED vs JEPISMED vs OSMED vs KOSMED vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.